Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Refractory anemia with ringed sideroblasts
0.030 GeneticVariation BEFREE Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis. 20194893 2010
Refractory anemia with ringed sideroblasts
0.030 GeneticVariation BEFREE Refractory anemia with ringed sideroblasts and marked thrombocytosis (RARS-T) was recently shown to be a JAK2-V617F mutation-related disorder. 18166783 2008
Refractory anemia with ringed sideroblasts
0.030 GeneticVariation BEFREE Within this group, most of the patients harboring JAK2 V617F mutation showed features consistent with the provisional MDS/MPD-U entity refractory anemia with ringed sideroblasts and thrombocytosis (RARS-T). 16741247 2006